Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 17 shares at $105.11 ($2K) on 2018-12-28, disclosed to the SEC on 2023-05-03.
Tax-driven sale ($2k) by Director — typically RSU/option vesting with shares sold to cover withholding tax. Not a directional view.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $121.01 | 6 | $726 | 38.3% |
| 2 | $107.71 | 5 | $539 | 28.4% |
| 3 | $104.12 | 2 | $208 | 11.0% |
| 4 | $105.11 | 4 | $420 | 22.2% |
| Total | $111.37 avg | 17 | $2K | 100% |
| Filing → |
| UTHR | SELL | 2025-12-16 | $496K | — | Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |